Skip to main content
Erschienen in: Annals of Behavioral Medicine 1/2017

26.09.2016 | Original Article

Predictors of Smoking Cessation and Relapse in Cancer Patients and Effect on Psychological Variables: an 18-Month Observational Study

verfasst von: Anne-Josée Guimond, MA, Virginie A. Croteau, BA, Marie-Hélène Savard, PhD, Paquito Bernard, PhD, Hans Ivers, PhD, Josée Savard, PhD

Erschienen in: Annals of Behavioral Medicine | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Although cancer patients are generally strongly advised to quit smoking in order to improve treatment efficacy and survival, up to 68 % of patients who were smokers at the time of cancer diagnosis continue smoking. Psychological factors such as depression and anxiety are likely to be associated with smoking behavior following a cancer diagnosis, but the empirical evidence is scarce.

Purpose

This observational study aimed at estimating smoking cessation rates and assessing the effect of smoking cessation on psychological symptoms, as well as the predictive role of the same psychological variables on smoking cessation and smoking relapse following cancer surgery.

Methods

As part of a larger prospective, epidemiological study, smokers (n = 175) with a first diagnosis of nonmetastatic cancer completed the Hospital Anxiety and Depression Scale, the Insomnia Severity Index, and the Fear of Cancer Recurrence Inventory. Quitters (n = 55) and pair-matched nonquitters (n = 55) were compared on each symptom at pre-quitting, post-quitting, and at a 4-month follow-up. Predictors of smoking cessation and smoking relapse, including psychological variables, were also investigated.

Results

Fifty-five patients (31.4 %) stopped smoking at least on one occasion during the study. Of the 55 quitters, 27 (49.1 %) experienced a relapse. At pre-quitting, quitters had significantly higher levels of anxiety (p = .03) and fear of cancer recurrence (p = .01) than nonquitters, symptoms that significantly diminished at post-quitting and 4 months later in this subgroup of patients. Having breast cancer significantly predicted smoking cessation (relative risk [RR] = 3.08), while depressive symptoms were a significant predictor of smoking relapse (RR = 1.07).

Conclusions

This study highlights the importance of psychological symptoms in predicting tobacco cessation and relapse among individuals with cancer. Our findings suggest that breast cancer patients are more inclined to stop smoking than patients with other cancers, but future studies should attempt to delineate the effect on smoking cessation of gender and other demographics that characterize this subgroup. This study also suggests that a particular attention should be paid to the early management of depressive symptoms in order to prevent smoking relapse.
Literatur
2.
Zurück zum Zitat Sitas F, Weber MF, Egger S, Yap S, Chiew M, O’Connell D. Smoking cessation after cancer. J Clin Oncol. 2014; 32(32):3593–3595.CrossRefPubMed Sitas F, Weber MF, Egger S, Yap S, Chiew M, O’Connell D. Smoking cessation after cancer. J Clin Oncol. 2014; 32(32):3593–3595.CrossRefPubMed
3.
Zurück zum Zitat Aveyard P, Adab P, Cheng KK. Does smoking status influence the prognosis of bladder cancer? A systematic review. BJU International. 2002; 90(3):228–239.CrossRefPubMed Aveyard P, Adab P, Cheng KK. Does smoking status influence the prognosis of bladder cancer? A systematic review. BJU International. 2002; 90(3):228–239.CrossRefPubMed
4.
Zurück zum Zitat Chen CH, Shun CT, Huang KH, et al. Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer. BJU International. 2007; 100(2):281–286.CrossRefPubMed Chen CH, Shun CT, Huang KH, et al. Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer. BJU International. 2007; 100(2):281–286.CrossRefPubMed
5.
Zurück zum Zitat Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: Systematic review of observational studies with meta-analysis. Br Med J. 2010; 340:b5569-b5569.CrossRef Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: Systematic review of observational studies with meta-analysis. Br Med J. 2010; 340:b5569-b5569.CrossRef
6.
Zurück zum Zitat Pytynia KB, Grant JR. Matched-pair analysis of survival of never smokers and ever smokers with squamous cell carcinoma of the head and neck. J Clin Oncol. 2004; 22(19):3981–3988.CrossRefPubMed Pytynia KB, Grant JR. Matched-pair analysis of survival of never smokers and ever smokers with squamous cell carcinoma of the head and neck. J Clin Oncol. 2004; 22(19):3981–3988.CrossRefPubMed
7.
Zurück zum Zitat Fleshner N, Garland JA, Moadel A, Herr H. Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder. Cancer. 1999; 86(11):2337–2345.CrossRefPubMed Fleshner N, Garland JA, Moadel A, Herr H. Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder. Cancer. 1999; 86(11):2337–2345.CrossRefPubMed
8.
Zurück zum Zitat Do KA, Johnson MM, Lee JJ, Wu XF. Study of smoking patterns in relation to the development of smoking-related secondary primary tumors in patients with upper aerodigestive tract malignancies. Cancer. 2004; 101(12):2837–2842.CrossRefPubMed Do KA, Johnson MM, Lee JJ, Wu XF. Study of smoking patterns in relation to the development of smoking-related secondary primary tumors in patients with upper aerodigestive tract malignancies. Cancer. 2004; 101(12):2837–2842.CrossRefPubMed
9.
Zurück zum Zitat Peppone LJ, Reid ME, Moysich KB, et al. The effect of secondhand smoke exposure on the association between active cigarette smoking and colorectal cancer. Cancer Cause Control. 2010; 21:1247–1255.CrossRef Peppone LJ, Reid ME, Moysich KB, et al. The effect of secondhand smoke exposure on the association between active cigarette smoking and colorectal cancer. Cancer Cause Control. 2010; 21:1247–1255.CrossRef
10.
Zurück zum Zitat Walker MS, Larsen RJ, Zona DM. Smoking urges and relapse among lung cancer patients: Findings from a preliminary retrospective study. Prev Med. 2004; 39(3):449–457.CrossRefPubMed Walker MS, Larsen RJ, Zona DM. Smoking urges and relapse among lung cancer patients: Findings from a preliminary retrospective study. Prev Med. 2004; 39(3):449–457.CrossRefPubMed
11.
Zurück zum Zitat Bell RJ, Lijovic M, Fradkin P, Schwarz M, Davis SR. Changes in patterns of use of cigarettes and alcohol in women after a first diagnosis of invasive breast cancer: A cohort study of women from Victoria, Australia. Support Care Cancer. 2012; 20(4):783–789.CrossRefPubMed Bell RJ, Lijovic M, Fradkin P, Schwarz M, Davis SR. Changes in patterns of use of cigarettes and alcohol in women after a first diagnosis of invasive breast cancer: A cohort study of women from Victoria, Australia. Support Care Cancer. 2012; 20(4):783–789.CrossRefPubMed
12.
Zurück zum Zitat Westmaas JL, Newton CC, Stevens VL, Flanders WD, Gapstur SM, Jacobs EJ. Does a recent cancer diagnosis predict smoking cessation? An analysis from a large prospective US cohort. J Clin Oncol. 2015. Westmaas JL, Newton CC, Stevens VL, Flanders WD, Gapstur SM, Jacobs EJ. Does a recent cancer diagnosis predict smoking cessation? An analysis from a large prospective US cohort. J Clin Oncol. 2015.
13.
Zurück zum Zitat Balbani APS, Montovani JC. Methods for smoking cessation and treatment of nicotine dependence. Braz J Otorhinolaryngol. 2005; 71(6):820–827.CrossRefPubMed Balbani APS, Montovani JC. Methods for smoking cessation and treatment of nicotine dependence. Braz J Otorhinolaryngol. 2005; 71(6):820–827.CrossRefPubMed
14.
Zurück zum Zitat Fagerström K. The epidemiology of smoking: Health consequences and benefits of cessation. Drugs. 2002; 62 Suppl 2:1–9.CrossRefPubMed Fagerström K. The epidemiology of smoking: Health consequences and benefits of cessation. Drugs. 2002; 62 Suppl 2:1–9.CrossRefPubMed
15.
Zurück zum Zitat Hughes JR. Effects of abstinence from tobacco: Valid symptoms and time course. Nicotine Tob Res. 2007; 9(3):315–327.CrossRefPubMed Hughes JR. Effects of abstinence from tobacco: Valid symptoms and time course. Nicotine Tob Res. 2007; 9(3):315–327.CrossRefPubMed
17.
Zurück zum Zitat Underner M, Paquereau J, Meurice JC. Tabagisme et troubles du sommeil. Rev Mal Respir. 2006; 23:67–77.CrossRef Underner M, Paquereau J, Meurice JC. Tabagisme et troubles du sommeil. Rev Mal Respir. 2006; 23:67–77.CrossRef
18.
Zurück zum Zitat Hughes JR, Higgins ST, Bickel WK. Nicotine withdrawal versus other drug withdrawal syndromes: Similarities and dissimilarities. Addiction. 1994; 89(11):1461–1470.CrossRefPubMed Hughes JR, Higgins ST, Bickel WK. Nicotine withdrawal versus other drug withdrawal syndromes: Similarities and dissimilarities. Addiction. 1994; 89(11):1461–1470.CrossRefPubMed
19.
Zurück zum Zitat Augustson EM, Wanke KL, Rogers S, et al. Predictors of sustained smoking cessation: A prospective analysis of chronic smokers from the alpha-tocopherol Beta-Carotene Cancer Prevention Study. Am J Public Health. 2008; 98(3):549–555.CrossRefPubMedPubMedCentral Augustson EM, Wanke KL, Rogers S, et al. Predictors of sustained smoking cessation: A prospective analysis of chronic smokers from the alpha-tocopherol Beta-Carotene Cancer Prevention Study. Am J Public Health. 2008; 98(3):549–555.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Cinciripini PM, Wetter DW, Fouladi RT, et al. The effects of depressed mood on smoking cessation: Mediation by postcessation self-efficacy. J Consult Clinical Psych. 2003; 71(2):292–301.CrossRef Cinciripini PM, Wetter DW, Fouladi RT, et al. The effects of depressed mood on smoking cessation: Mediation by postcessation self-efficacy. J Consult Clinical Psych. 2003; 71(2):292–301.CrossRef
21.
Zurück zum Zitat Cooley ME, Sarna L, Brown JK, et al. Tobacco use in women with lung cancer. Ann Behav Med. 2007; 33(3):242–250.CrossRefPubMed Cooley ME, Sarna L, Brown JK, et al. Tobacco use in women with lung cancer. Ann Behav Med. 2007; 33(3):242–250.CrossRefPubMed
22.
Zurück zum Zitat Bloom EL, Oliver JA, Sutton SK, Brandon TH, Jacobsen PB, Simmons VN. Post-operative smoking status in lung and head and neck cancer patients: Association with depressive symptomatology, pain, and fatigue. Psycho-Oncol. 2014; 24(9):1012–1019.CrossRef Bloom EL, Oliver JA, Sutton SK, Brandon TH, Jacobsen PB, Simmons VN. Post-operative smoking status in lung and head and neck cancer patients: Association with depressive symptomatology, pain, and fatigue. Psycho-Oncol. 2014; 24(9):1012–1019.CrossRef
23.
Zurück zum Zitat Pomerleau OF, Pomerleau CS, Marks JL. Abstinence effects and reactivity to nicotine during 11 days of smoking deprivation. Nicotine Tob Res. 2000; 2(2):149–157.CrossRefPubMed Pomerleau OF, Pomerleau CS, Marks JL. Abstinence effects and reactivity to nicotine during 11 days of smoking deprivation. Nicotine Tob Res. 2000; 2(2):149–157.CrossRefPubMed
24.
Zurück zum Zitat Colrain I, Trinder J, Swan G. The impact of smoking cessation on objective and subjective markers of sleep: Review, synthesis, and recommendations. Nicotine Tob Res. 2004; 6(6):913–925.CrossRefPubMed Colrain I, Trinder J, Swan G. The impact of smoking cessation on objective and subjective markers of sleep: Review, synthesis, and recommendations. Nicotine Tob Res. 2004; 6(6):913–925.CrossRefPubMed
25.
Zurück zum Zitat Swan GE, Ward MM, Jack LM. Abstinence affects as predictors of 28-day relapse in smokers. Addict Behav. 1996; 21(4):481–490.CrossRefPubMed Swan GE, Ward MM, Jack LM. Abstinence affects as predictors of 28-day relapse in smokers. Addict Behav. 1996; 21(4):481–490.CrossRefPubMed
26.
Zurück zum Zitat Niaura R, Britt DM, Shadel WG, Goldstein M, Abrams D, Brown R. Symptoms of depression and survival experience among three samples of smokers trying to quit. Psychol Addict Behav. 2001; 15(1):13–17.CrossRefPubMed Niaura R, Britt DM, Shadel WG, Goldstein M, Abrams D, Brown R. Symptoms of depression and survival experience among three samples of smokers trying to quit. Psychol Addict Behav. 2001; 15(1):13–17.CrossRefPubMed
27.
Zurück zum Zitat Shiffman S, Waters AJ. Negative affect and smoking lapses: A prospective analysis. J Consult Clinical Psych. 2004; 72(2):192–201.CrossRef Shiffman S, Waters AJ. Negative affect and smoking lapses: A prospective analysis. J Consult Clinical Psych. 2004; 72(2):192–201.CrossRef
28.
Zurück zum Zitat Weinberger AH, Mazure CM, Morlett A, McKee SA. Two decades of smoking cessation treatment research on smokers with depression: 1990–2010. Nicotine Tob Res. 2013; 15(6):1014–1031.CrossRefPubMed Weinberger AH, Mazure CM, Morlett A, McKee SA. Two decades of smoking cessation treatment research on smokers with depression: 1990–2010. Nicotine Tob Res. 2013; 15(6):1014–1031.CrossRefPubMed
29.
Zurück zum Zitat Kinnunen T, Korhonen T, Garvey AJ. Role of nicotine gum and pretreatment depressive symptoms in smoking cessation: Twelve-month results of a randomized placebo controlled trial. Int J Psychiat Med. 2008; 38(3):373–389.CrossRef Kinnunen T, Korhonen T, Garvey AJ. Role of nicotine gum and pretreatment depressive symptoms in smoking cessation: Twelve-month results of a randomized placebo controlled trial. Int J Psychiat Med. 2008; 38(3):373–389.CrossRef
30.
Zurück zum Zitat Haas AL, Muñoz RF, Humfleet GL, Reus VI, Hall SM. Influences of mood, depression history, and treatment modality on outcomes in smoking cessation. J Consult Clinical Psych. 2004; 72:563–570.CrossRef Haas AL, Muñoz RF, Humfleet GL, Reus VI, Hall SM. Influences of mood, depression history, and treatment modality on outcomes in smoking cessation. J Consult Clinical Psych. 2004; 72:563–570.CrossRef
31.
Zurück zum Zitat Piper ME, Schlam TR, Cook JW, et al. Tobacco withdrawal components and their relations with cessation success. Psychopharmacology. 2011; 216(4):569–578.CrossRefPubMedPubMedCentral Piper ME, Schlam TR, Cook JW, et al. Tobacco withdrawal components and their relations with cessation success. Psychopharmacology. 2011; 216(4):569–578.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Covey LS, Glassman, AH, Stetner F. Major depression following smoking cessation. Am J Psychiat. 1997; 154(2):263–265.CrossRefPubMed Covey LS, Glassman, AH, Stetner F. Major depression following smoking cessation. Am J Psychiat. 1997; 154(2):263–265.CrossRefPubMed
33.
Zurück zum Zitat Gritz ER, Schacherer C, Koehly L. Smoking withdrawal and relapse in head and neck cancer patients. Head Neck. 1999; 21(5):420–427.CrossRefPubMed Gritz ER, Schacherer C, Koehly L. Smoking withdrawal and relapse in head and neck cancer patients. Head Neck. 1999; 21(5):420–427.CrossRefPubMed
34.
Zurück zum Zitat Cox LS, Africano NL, Tercyak KP, Taylor KL. Nicotine dependence treatment for patients with cancer. Cancer. 2003; 98(3):632–644.CrossRefPubMed Cox LS, Africano NL, Tercyak KP, Taylor KL. Nicotine dependence treatment for patients with cancer. Cancer. 2003; 98(3):632–644.CrossRefPubMed
35.
Zurück zum Zitat Martinez E, Tatum KL, Weber DM. Issues related to implementing a smoking cessation clinical trial for cancer patients. Cancer Cause Control. 2009; 20(1):97–104.CrossRef Martinez E, Tatum KL, Weber DM. Issues related to implementing a smoking cessation clinical trial for cancer patients. Cancer Cause Control. 2009; 20(1):97–104.CrossRef
36.
Zurück zum Zitat Schnoll R, Martinez E, Tatum KL. A bupropion smoking cessation clinical trial for cancer patients. Cancer Cause Control. 2010; 21(6):811–820.CrossRef Schnoll R, Martinez E, Tatum KL. A bupropion smoking cessation clinical trial for cancer patients. Cancer Cause Control. 2010; 21(6):811–820.CrossRef
37.
Zurück zum Zitat Blalock JA, Lam C, Minnix JA, et al. The effect of mood, anxiety, and alcohol use disorders on smoking cessation in cancer patients. J Cogn Psychother. 2011;25(1):82–96.CrossRef Blalock JA, Lam C, Minnix JA, et al. The effect of mood, anxiety, and alcohol use disorders on smoking cessation in cancer patients. J Cogn Psychother. 2011;25(1):82–96.CrossRef
38.
Zurück zum Zitat Simmons VN, Litvin EB, Jacobsen PB, et al. Predictors of smoking relapse in patients with thoracic cancer or head and neck cancer. Cancer. 2013;119(7):1420–1427.CrossRefPubMed Simmons VN, Litvin EB, Jacobsen PB, et al. Predictors of smoking relapse in patients with thoracic cancer or head and neck cancer. Cancer. 2013;119(7):1420–1427.CrossRefPubMed
39.
Zurück zum Zitat Savard J, Ivers H, Villa J, Caplette-Gingras A, Morin CM. Natural course of insomnia comorbid with cancer: An 18-month longitudinal study. J Clin Oncol. 2011;29:3580–3586.CrossRefPubMed Savard J, Ivers H, Villa J, Caplette-Gingras A, Morin CM. Natural course of insomnia comorbid with cancer: An 18-month longitudinal study. J Clin Oncol. 2011;29:3580–3586.CrossRefPubMed
40.
Zurück zum Zitat Savard J, Villa J, Ivers H, Simard S, Morin CM. Prevalence, natural course, and risk factors of insomnia comorbid with cancer over a 2-month period. J Clin Oncol. 2009;27:5233–5239.CrossRefPubMed Savard J, Villa J, Ivers H, Simard S, Morin CM. Prevalence, natural course, and risk factors of insomnia comorbid with cancer over a 2-month period. J Clin Oncol. 2009;27:5233–5239.CrossRefPubMed
41.
Zurück zum Zitat Morin CM, Barlow DH. Insomnia: Psychological Assessment and Management Guilford Press New York; 1993. Morin CM, Barlow DH. Insomnia: Psychological Assessment and Management Guilford Press New York; 1993.
42.
Zurück zum Zitat Savard MH, Savard J, Simard S, Ivers H. Empirical validation of the insomnia severity index in cancer patients. Psycho-Oncol. 2005;14:429–441.CrossRef Savard MH, Savard J, Simard S, Ivers H. Empirical validation of the insomnia severity index in cancer patients. Psycho-Oncol. 2005;14:429–441.CrossRef
43.
Zurück zum Zitat Savard J, Laberge B, Gauthier JG, Ivers H, Bergeron MG. Evaluating anxiety and depression in HIV-infected patients. J Pers Assess. 1998;71:349–367.CrossRefPubMed Savard J, Laberge B, Gauthier JG, Ivers H, Bergeron MG. Evaluating anxiety and depression in HIV-infected patients. J Pers Assess. 1998;71:349–367.CrossRefPubMed
44.
Zurück zum Zitat Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiat Scand. 1983;67:361–370.CrossRefPubMed Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiat Scand. 1983;67:361–370.CrossRefPubMed
45.
Zurück zum Zitat Simard S, Savard J. Fear of cancer recurrence inventory: Development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2009;17:241–251.CrossRefPubMed Simard S, Savard J. Fear of cancer recurrence inventory: Development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2009;17:241–251.CrossRefPubMed
46.
Zurück zum Zitat Zou G. A Modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–706.CrossRefPubMed Zou G. A Modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–706.CrossRefPubMed
47.
Zurück zum Zitat Walker MS, Vidrine DJ, Gritz ER. Smoking relapse during the first year after treatment for early-stage non–small-cell lung cancer. Cancer Epidemiol Biomarkers Prev. 2006;15(12):2370–2377.CrossRefPubMed Walker MS, Vidrine DJ, Gritz ER. Smoking relapse during the first year after treatment for early-stage non–small-cell lung cancer. Cancer Epidemiol Biomarkers Prev. 2006;15(12):2370–2377.CrossRefPubMed
48.
Zurück zum Zitat Wetter DW, Carmack CL, Anderson CB, et al. Tobacco withdrawal signs and symptoms among women with and without a history of depression. Exp Clin Psychopharmacol. 2000;8(1):88. Wetter DW, Carmack CL, Anderson CB, et al. Tobacco withdrawal signs and symptoms among women with and without a history of depression. Exp Clin Psychopharmacol. 2000;8(1):88.
49.
Zurück zum Zitat Jaehne A, Unbehaun T, Feige B, Cohrs S, Rodenbeck A, Riemann D. Sleep changes in smokers before, during and 3 months after nicotine withdrawal. Addict Biol. 2014. Jaehne A, Unbehaun T, Feige B, Cohrs S, Rodenbeck A, Riemann D. Sleep changes in smokers before, during and 3 months after nicotine withdrawal. Addict Biol. 2014.
50.
Zurück zum Zitat Gilbert DG, McClernon FJ, Rabinovich NE, et al. Mood disturbance fails to resolve across 31 days of cigarette abstinence in women. 2002;70:142–152. Gilbert DG, McClernon FJ, Rabinovich NE, et al. Mood disturbance fails to resolve across 31 days of cigarette abstinence in women. 2002;70:142–152.
51.
Zurück zum Zitat Ward MM, Swan GE, Jack LM. Self-reported abstinence effects in the first month after smoking cessation. Addict Behav. 2001;26(3):311–327.CrossRefPubMed Ward MM, Swan GE, Jack LM. Self-reported abstinence effects in the first month after smoking cessation. Addict Behav. 2001;26(3):311–327.CrossRefPubMed
52.
Zurück zum Zitat Schnoll R, Rothman RL, Newman H, et al. Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: Implications for the development of tobacco control programs for cancer patients Psycho-Oncol. 2004;13(5):346–358.CrossRef Schnoll R, Rothman RL, Newman H, et al. Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: Implications for the development of tobacco control programs for cancer patients Psycho-Oncol. 2004;13(5):346–358.CrossRef
53.
Zurück zum Zitat Schnoll R, Calvin J, Malstrom M. Longitudinal predictors of continued tobacco use among patients diagnosed with cancer. Ann Behav Med. 2003;25(3):214–222.CrossRefPubMed Schnoll R, Calvin J, Malstrom M. Longitudinal predictors of continued tobacco use among patients diagnosed with cancer. Ann Behav Med. 2003;25(3):214–222.CrossRefPubMed
54.
Zurück zum Zitat Trudel-Fitzgerald C, Savard J, Ivers H. Evolution of cancer-related symptoms over an 18-month period. J Pain Symptom Manage. 2013;45:1007–1018.CrossRefPubMed Trudel-Fitzgerald C, Savard J, Ivers H. Evolution of cancer-related symptoms over an 18-month period. J Pain Symptom Manage. 2013;45:1007–1018.CrossRefPubMed
55.
Zurück zum Zitat Hughes JR. Tobacco withdrawal in self-quitters. J Consult Clinical Psych. 1992;60(5):689–697.CrossRef Hughes JR. Tobacco withdrawal in self-quitters. J Consult Clinical Psych. 1992;60(5):689–697.CrossRef
56.
Zurück zum Zitat Tate JC, Stanton AL, Green SB, Schmitz JM. Assessing the validity of nicotine abstinence effects by self-and observer ratings under “blinded” conditions. Exp Clin Psychopharmacol. 1996;4(3):330.CrossRef Tate JC, Stanton AL, Green SB, Schmitz JM. Assessing the validity of nicotine abstinence effects by self-and observer ratings under “blinded” conditions. Exp Clin Psychopharmacol. 1996;4(3):330.CrossRef
57.
Zurück zum Zitat Brown RA, Kahler CW, Niaura R, et al. Cognitive–behavioral treatment for depression in smoking cessation. J Consult Clinical Psych. 2001;69(3):471–480.CrossRef Brown RA, Kahler CW, Niaura R, et al. Cognitive–behavioral treatment for depression in smoking cessation. J Consult Clinical Psych. 2001;69(3):471–480.CrossRef
58.
Zurück zum Zitat Burgess ES, Brown RA, Kahler CW, et al. Patterns of change in depressive symptoms during smoking cessation: Who’s at risk for relapse? J Consult Clinical Psych. 2002;70:356–361.CrossRef Burgess ES, Brown RA, Kahler CW, et al. Patterns of change in depressive symptoms during smoking cessation: Who’s at risk for relapse? J Consult Clinical Psych. 2002;70:356–361.CrossRef
59.
Zurück zum Zitat Gritz ER, Carr CR, Rapkin D. Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 1993;2:261–270.PubMed Gritz ER, Carr CR, Rapkin D. Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 1993;2:261–270.PubMed
60.
Zurück zum Zitat Ostroff JS, Jacobsen PB, Moadel AB. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer. 1995;2(75):569–576.CrossRef Ostroff JS, Jacobsen PB, Moadel AB. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer. 1995;2(75):569–576.CrossRef
61.
Zurück zum Zitat Reid JL, Hammond D, Boudreau C, Fong GT, Siahpush M. Socioeconomic disparities in quit intentions, quit attempts, and smoking abstinence among smokers in four western countries: Findings from the International Tobacco Control Four Country Survey. Nicotine Tob Res. 2010;12 Suppl(October):S20–33.CrossRefPubMedPubMedCentral Reid JL, Hammond D, Boudreau C, Fong GT, Siahpush M. Socioeconomic disparities in quit intentions, quit attempts, and smoking abstinence among smokers in four western countries: Findings from the International Tobacco Control Four Country Survey. Nicotine Tob Res. 2010;12 Suppl(October):S20–33.CrossRefPubMedPubMedCentral
62.
Zurück zum Zitat Smit ES, Hoving C, Schelleman-Offermans K, West R, de Vries H. Predictors of successful and unsuccessful quit attempts among smokers motivated to quit. Addict Behav. 2014;39(9):1318–1324.CrossRefPubMed Smit ES, Hoving C, Schelleman-Offermans K, West R, de Vries H. Predictors of successful and unsuccessful quit attempts among smokers motivated to quit. Addict Behav. 2014;39(9):1318–1324.CrossRefPubMed
63.
Zurück zum Zitat MacPherson L, Tull MT, Matusiewicz AK, et al. Randomized controlled trial of behavioral activation smoking cessation treatment for smokers with elevated depressive symptoms. J Consult Clinical Psych. 2010;78(1):55.CrossRef MacPherson L, Tull MT, Matusiewicz AK, et al. Randomized controlled trial of behavioral activation smoking cessation treatment for smokers with elevated depressive symptoms. J Consult Clinical Psych. 2010;78(1):55.CrossRef
64.
Zurück zum Zitat Savard J, Morin CM. Insomnia in the context of cancer: A review of a neglected problem. J Clin Oncol. 2001;19:895–908.PubMed Savard J, Morin CM. Insomnia in the context of cancer: A review of a neglected problem. J Clin Oncol. 2001;19:895–908.PubMed
65.
Zurück zum Zitat Savard J, Savard M-H. Insomnia and cancer: Prevalence, nature, and nonpharmacologic treatment. Sleep Med Clin. 2013;8(3):373–387.CrossRef Savard J, Savard M-H. Insomnia and cancer: Prevalence, nature, and nonpharmacologic treatment. Sleep Med Clin. 2013;8(3):373–387.CrossRef
Metadaten
Titel
Predictors of Smoking Cessation and Relapse in Cancer Patients and Effect on Psychological Variables: an 18-Month Observational Study
verfasst von
Anne-Josée Guimond, MA
Virginie A. Croteau, BA
Marie-Hélène Savard, PhD
Paquito Bernard, PhD
Hans Ivers, PhD
Josée Savard, PhD
Publikationsdatum
26.09.2016
Verlag
Springer US
Erschienen in
Annals of Behavioral Medicine / Ausgabe 1/2017
Print ISSN: 0883-6612
Elektronische ISSN: 1532-4796
DOI
https://doi.org/10.1007/s12160-016-9834-4

Weitere Artikel der Ausgabe 1/2017

Annals of Behavioral Medicine 1/2017 Zur Ausgabe

Neu in den Fachgebieten Neurologie und Psychiatrie

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Vierten reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.